Randomized Study of Two Dose Levels of Privigen in Pediatric CIDP

  • End date
    Jan 22, 2027
  • participants needed
  • sponsor
    CSL Behring
Updated on 22 September 2022


A randomized, open-label, prospective, multicenter study designed to investigate 2 dose levels in pediatric subjects 2 to ≤ 17 years of age with confirmed or possible CIDP, either previously exposed to IVIG treatment or unexposed to IVIG treatment

Condition Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Treatment IgPro10
Clinical Study IdentifierNCT03684018
SponsorCSL Behring
Last Modified on22 September 2022


Yes No Not Sure

Inclusion Criteria

Male or female subjects 2 to ≤ 17 years of age with confirmed or possible CIDP

Exclusion Criteria

Absence of CIDP symptoms
History or family history of inherited neuropathy
Diagnosed developmental delay or regression
History of thrombotic episode
Known or suspected hypersensitivity to Privigen
Known allergic or other severe reactions to blood products
Female subject of childbearing potential either not using or not willing to use a medically reliable method of contraception or not sexually abstinent during the study
Pregnant or breastfeeding mother
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note